REFERENCES
- Livingstone FB. Malaria and human polymorphisms. Ann Rev Genet 1971; 5: 33–38
- Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, Gulbis B, Hopmeier P, Lena-Russo D, Romao L, Theodorsson E. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007; 67(1)39–69
- Davies SC, Cronin E, Gill M, Hickman M, Normand D. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess 2000; 4(3)1–99
- Bardakjian-Michau J. Neonatal detection of sickle cell disease. J Gynecol Obstet Biol Reprod (Paris) 2003; 32(Suppl 1)1S61–1S64
- Giordano PC, Harteveld CL. Prevention of hereditary haemoglobinopathies in The Netherlands. Ned Tijdschr Geneeskd 2006; 150(39)2137–2141
- Giordano PC, Plancke A, Van Meir CA, Janssen CA, Kok PJ, Van Rooijen-Nijdam IH, Tanis BC, van Huisseling JC, Versteegh FG. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study. Prenat Diagn 2006; 26(8)719–724
- Giordano PC, Bouva MJ, Harteveld CL. A confidential inquiry estimating the number of patients affected with sickle cell disease and thalassemia major confirms the need for a prevention strategy in The Netherlands. Hemoglobin 2004; 28(4)287–296
- Gulbis B, Ferster A, Cotton F, Lebouchard MP, Cochaux P, Vertongen F. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels. J Med Screen 2006; 13(2)76–78
- http://www.ecfs.eu/ECFRegistry/AnnualECFRegistryReports.htm
- World Health Organization. The molecular genetic epidemiology of cystic fibrosis. Report of a joint meeting of WHO/ECFTN/ICF/(M)A/A/ECFS. Genoa, Italy, June 2002. WHO/HGN/CF/WG/04.02
- Badens C, North ML, Lena-Russo D. β Thalassemia in Metropolitan France. Press Med 2003; 32(22)1016–1021
- Giordano PC, Dihal AA, Harteveld CL. Estimating the attitude of immigrants toward primary prevention of the hemoglobinopathies. Prenat Diagn 2005; 25(10)885–893